6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.4B | $10M | 0.0% | 1.7% | $110M | $283M | $249M |
| 2024 | $1.3B | -$57M | 0.0% | -2.5% | $86M | $290M | $155M |
| 2023 | $1.1B | -$186M | 0.0% | -17.9% | -$57M | $289M | $79M |
| 2022 | $860M | -$216M | 0.0% | -24.5% | -$26M | $234M | $109M |
| 2021 | $668M | -$307M | 0.0% | -42.9% | -$85M | $161M | $148M |
| 2019 | $213M | $6M | 0.0% | 7.2% | $3M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $403M | $14M | 0.0% | 5.5% | $22M | $283M | $195M |
| Dec '25 | $382M | $12M | 0.0% | 4.7% | $47M | $283M | $249M |
| Sep '25 | $364M | $1M | 0.0% | 2.0% | $17M | $285M | $204M |
| Jun '25 | $345M | -$4M | 0.0% | -0.9% | $57M | $286M | $189M |
| Mar '25 | $333M | $709000 | 0.0% | 0.5% | -$10M | $288M | $134M |
| Dec '24 | $325M | -$7M | 0.0% | 0.3% | $56M | $290M | $155M |
| Sep '24 | $313M | $709000 | 0.0% | 0.0% | $18M | $287M | $103M |
| Jun '24 | $312M | -$23M | 0.0% | -5.1% | $39M | $288M | $87M |
| Mar '24 | $300M | -$21M | 0.0% | -5.6% | -$27M | $289M | $49M |
| Dec '23 | $281M | -$45M | 0.0% | -11.5% | $5M | $289M | $79M |
| Sep '23 | $263M | -$62M | 0.0% | -28.3% | -$35M | $257M | $43M |
| Jun '23 | $260M | -$45M | 0.0% | -18.7% | -$12M | $258M | $80M |
| Mar '23 | $253M | -$34M | 0.0% | -13.5% | -$16M | $233M | $68M |
| Dec '22 | $229M | -$47M | 0.0% | -20.1% | $26M | $234M | $109M |
| Sep '22 | $218M | -$38M | 0.0% | -17.9% | -$9M | $221M | $90M |
| Jun '22 | $210M | -$69M | 0.0% | -28.9% | -$18M | $211M | $97M |
| Mar '22 | $203M | -$62M | 0.0% | -31.9% | -$25M | $181M | $114M |
| Dec '21 | $190M | -$108M | 0.0% | -59.9% | -$8M | $161M | $148M |
| Sep '21 | $174M | -$120M | 0.0% | -71.7% | -$38M | $162M | $212M |
| Jun '21 | $161M | -$70M | 0.0% | -29.3% | -$38M | $162M | $276M |
How the market has priced LFST against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Lifestance Health Group, Inc.'s revenue has grown 20.9% per year. These are computed facts, not advice.
As of FY2025, Lifestance Health Group, Inc. reported $283M of total debt against $249M of cash; operating income covered interest expense 2.1×.
In FY2025, gross margin was —, operating margin 1.7%, and net margin 0.7%.
As of Jun '26, Lifestance Health Group, Inc. traded at a price-to-earnings ratio of about 396.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.